Search clinical trials for: Any drug-eluting stent

Total 256659 results

Conor Medsystems

Terminated

Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation) (DECIDE)

Coronary Artery Disease

Germany
Meril Life Sciences Pvt. Ltd.

Unknown

Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. (Morph RCT-1)

Coronary Artery Disease
MINVASYS

Completed

Safety and Efficacy Study of the Nile PAX Drug-Eluting Coronary Bifurcation Stent (BIPAX)

Coronary Disease

Bulgaria, France, Italy, Brazil, Netherlands, Poland, Spain
CardioVascular Research Foundation, Korea

Completed

Comparison of Paclitaxel-Eluting Coroflex Please Stent Versus Paclitaxel-Eluting Stent (PIPA)

Coronary Artery Disease

Korea, Republic of
Changhai Hospital

Unknown

Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures

Cholangiocarcinoma

China, Slovakia
Scitech Produtos Medicos Ltda

Unknown

INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique (insProvisional)

Coronary Artery Disease | Bifurcation Lesion

Brazil
CHEOL WHAN LEE, MD, PhD.
CardioVascular Research Foundation, Korea

Completed

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

Coronary Artery Disease

Korea, Republic of
Lepu Medical Technology (Beijing) Co., Ltd.

Not yet recruiting

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Coronary Artery Disease | Drug-coated Balloon
Zhejiang Zylox Medical Device Co., Ltd.

Recruiting

Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia (UltraFuture I)

Peripheral Arterial Disease (PAD)

China
Society for Advancement of Coronary Intervention...

Unknown

Small Coronary Artery Treated by TAXUS Liberté Registry in Japan (SACRA)

Stable Angina Pectoris | Unstable Angina Pectoris

Japan
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
San Giuseppe Moscati Hospital

Completed

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

ST Elevation Acute Myocardial Infarction

Italy
R&D Cardiologie
Cordis Corporation

Completed

Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (T-P)

Coronary Artery Disease | Coronary Stenosis

China
CID S.p.A.

Unknown

Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

Coronary Artery Disease

China
King Faisal Specialist Hospital & Research Center

Unknown

Drug Eluting Balloon for Early Fistula Failure Trial (DEBEFF)

Stenosis of Arteriovenous Dialysis Fistula

Saudi Arabia
Hospital Israelita Albert Einstein

Completed

Self-expandable Metallic Stent Versus Multiple Plastic Stents in Post Orthotopic Liver Transplantation Biliary Stenosis

Biliary Stricture | Biliary Anastomotic Stenosis

Brazil
University of Avignon

Completed

Myocardial Function and Vitamin D Supplementation in Diabetes. (VitaDD)

Diabetes Complications | Vitamin D Deficiency | Vitamin D Supplementation | Myocardial Dysfunction

France
China National Center for Cardiovascular Diseases

Unknown

Comparison of One-stop Hybrid Revascularization Versus Off-pump Coronary Artery Bypass for the Treatment of Multi-vessel Disease

Coronary Artery Disease

China
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions

Coronary Stenosis

United States
NYU Langone Health

Completed

Eponychial Stent Study

Nail Bed Injury | Eponychial Stent

United States
ZhuHai Cardionovum Medical Device Co., Ltd.
R&G Pharma Studies Co.,Ltd.

Completed

Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

Coronary Restenosis

China
Shanghai Bio-heart Biological Technology Co., Ltd.

Unknown

Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study

Heart Diseases
Beijing Tiantan Hospital

Recruiting

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial (DREAM-PRIDE)

Stroke | Intracranial Atherosclerotic Disease

China
VA Office of Research and Development

Completed

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA)

Saphenous Vein Graft Atherosclerosis

United States
Netherlands Society for Interventional Radiology

Active, not recruiting

PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI)

Peripheral Vascular Disease

Netherlands
Capital Medical University
Beijing Anzhen Hospital

Completed

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

Coronary Artery Disease

China
Boston Scientific Corporation

Completed

TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program (ARRIVE 2)

Cardiovascular Disease | de Novo Coronary Lesions

United States
Sahajanand Medical Technologies Limited
Cardiovascular European Research Center (CERC)

Completed

Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent

Coronary Artery Disease

Switzerland, Germany, France
Sunil Rao
Cordis Corporation

Completed

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Coronary Occlusions

United States, Canada
Cordis Corporation

Completed

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Coronary Artery Disease
Assiut University

Unknown

Predictors of Coronary Revascularization Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

Diabetes Mellitus, Type 2 With Acute Coronary Syndrom
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Intravascular Identification and Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques (DEBuT-LRP)

Coronary Artery Disease

Netherlands
Conor Medsystems

Completed

CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation

Coronary Disease

Belgium
Meril Life Sciences Pvt. Ltd.

Unknown

A Prospective, Single-arm, Multi-centre, Observational, Real World Registry (Morpheus)

Angina Pectoris

Jordan, Hungary, Malaysia, Netherlands
The PCI Guideline Research Society

Unknown

Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets (SPECIALIST)

Coronary Artery Disease

Japan
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Focal In-stent Restenosis After Drug-Eluting Stent (FOCUS)

In Stent Restenosis

Korea, Republic of
Alessandro Sciahbasi

Completed

Closed Versus Open Cells Stent for Acute Myocardial Infarction (COCHISE)

Acute Myocardial Infarction | Primary Percutaneous Coronary Intervention

Italy
Biotronik AG

Terminated

BIOFLOW-SV All Comers Registry (BIOFLOW-SV)

Restenoses, Coronary | de Novo | Symptomatic Ischemic Heart Disease

Brazil
Cordis Corporation

Completed

Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)

Coronary Artery Disease

United States
Ospedale Santa Maria Goretti

Withdrawn

VIBE-assisted DEB Registry (VIBER)

Coronary Artery Disease

Italy
Seoul National University Hospital
B. Braun Melsungen AG

Unknown

The Efficacies of The New Paclitaxel-Eluting CoroflexTM Please Stent in Percutaneous Coronary Intervention

Coronary Artery Disease
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Not yet recruiting

A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Coronary Artery Disease

China
Medical University of Warsaw
KCRI

Unknown

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) (ISRII)

In-Stent Restenosis

Poland
Medical University of South Carolina
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American...

Completed

Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures

Common Bile Duct Stricture

United States, United Kingdom
Marco Valgimigli

Completed

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PRODIGY)

Coronary Artery Disease

Italy
Translational Research Center for Medical Innovation...
Wakayama Medical University

Completed

OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging

Coronary Artery Disease

Japan
Heart Centre Rotenburg
B. Braun Melsungen AG; Clinical Research Institute, Center for Cardiovascular...

Completed

PEPCAD I. The Paclitaxel-Eluting PTCA-Balloon Catheter to Treat Small Vessel

Coronary Stenosis

Germany
Fondazione Ricerca e Innovazione Cardiovascolare...

Recruiting

Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels (TRANSFORM II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Netherlands, Italy, France, Bangladesh

Search clinical trials for: Any drug-eluting stent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations